The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures
Overview
Authors
Affiliations
All modern advances notwithstanding, pneumonia remains a common infection with substantial morbidity and mortality. Understanding of the etiology of pneumonia continues to evolve as new techniques enable identification of already known organisms and as new organisms emerge. We now review the etiology of pneumonia (at present often called "community-acquired pneumonia") beginning with classic bacteriologic techniques, which identified Streptococcus pneumoniae as the overwhelmingly common cause, to more modern bacteriologic studies, which emphasize Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, , Pseudomonas, and normal respiratory flora. Urine antigen detection is useful in identifying and pneumococcus. The low yield of bacteria in recent studies is due to the failure to obtain valid sputum samples before antibiotics are administered. The use of high-quality sputum specimens enables identification of recognized ("typical") bacterial pathogens as well as a role for commensal bacteria ("normal respiratory flora"). Nucleic acid amplification technology for viruses has revolutionized diagnosis, showing the importance of viral pneumonia leading to hospitalization with or without coinfecting bacterial organisms. Quantitative PCR study of sputum is in its early stages of application, but regular detection of high counts of bacterial DNA from organisms that are not seen on Gram stain or grown in quantitative culture presents a therapeutic dilemma. This finding may reflect the host microbiome of the respiratory tract, in which case treatment may not need to be given for them. Finally, host transcriptional signatures might enable clinicians to distinguish between viral and bacterial pneumonia, an important practical consideration.
Cai X, Xu M, Lu Y, Shen W, Kang J, Wang W BMC Microbiol. 2025; 25(1):139.
PMID: 40087562 DOI: 10.1186/s12866-025-03845-4.
Yu Y, Li M Mol Biol Rep. 2025; 52(1):309.
PMID: 40085176 DOI: 10.1007/s11033-025-10382-w.
Comparative analysis of the competence development versus during pneumonia-derived sepsis.
Chong S, Lew S, Alam T, Gaulke C, Lau G Front Microbiol. 2025; 16:1540511.
PMID: 39935640 PMC: 11811101. DOI: 10.3389/fmicb.2025.1540511.
Kim K, Yun S, Nam M, Lee C, Cho Y Microbiol Spectr. 2025; 13(3):e0228524.
PMID: 39882879 PMC: 11878093. DOI: 10.1128/spectrum.02285-24.
Impact of order set implementation on appropriate treatment of community-acquired pneumonia (CAP).
Pham H, Stein M, Worden L Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e7.
PMID: 39810857 PMC: 11729523. DOI: 10.1017/ash.2024.467.